Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Leisure Acquisition Corp (LACQ)

Leisure Acquisition Corp (LACQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 90,190
  • Shares Outstanding, K 6,224
  • Annual Sales, $ 0 K
  • Annual Income, $ 2,400 K
  • 60-Month Beta -0.30
  • Price/Sales N/A
  • Price/Cash Flow 20.03
  • Price/Book 47.62
Trade LACQ with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.40
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 08/06/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.0100 +31.61%
on 06/04/21
16.0000 -9.44%
on 06/11/21
+0.6400 (+4.62%)
since 05/28/21
3-Month
11.0100 +31.61%
on 06/04/21
16.0000 -9.44%
on 06/11/21
+1.5701 (+12.15%)
since 03/30/21
52-Week
10.1100 +43.32%
on 10/01/20
23.9900 -39.60%
on 02/01/21
+2.7799 (+23.74%)
since 06/30/20

Most Recent Stories

More News
Ensysce Biosciences Announces Notice of Allowance from the U.S. Patent and Trademark Office for Patent Entitled “Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof”

SAN DIEGO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with proprietary technology platforms...

LACQ : 14.4900 (unch)
ENSCW : 0.0360 (-8.40%)
LACQW : 1.0500 (unch)
ENSC : 0.5710 (-1.59%)
Ensysce Biosciences Bolsters Management Team with Appointments of David J. Kovacs as VP Public Policy and David Tanzer as VP Strategic Development

SAN DIEGO, July 26, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with proprietary technology platforms...

LACQ : 14.4900 (unch)
ENSCW : 0.0360 (-8.40%)
LACQW : 1.0500 (unch)
HGEN : 0.0002 (-84.62%)
BBIG : 0.0030 (unch)
AEYE : 12.47 (-4.15%)
ENSC : 0.5710 (-1.59%)
Ensysce Biosciences to Host Virtual Investor Day on July 27, 2021

SAN DIEGO, July 21, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical stage biotech company with proprietary technology platforms...

LACQ : 14.4900 (unch)
ENSC : 0.5710 (-1.59%)
ENSCW : 0.0360 (-8.40%)
LACQW : 1.0500 (unch)
Ensysce Biosciences Receives Notice of Award for Year Three of Multi-Year NIDA Grant for the Clinical Development of its Next Generation Opioid Products with Overdose Protection

Company’s Proprietary TAAP Prodrug Delivery and Overdose Technology Aims to Stem The Opioid Abuse Epidemic

LACQ : 14.4900 (unch)
ENSCW : 0.0360 (-8.40%)
LACQW : 1.0500 (unch)
ENSC : 0.5710 (-1.59%)
Ensysce Biosciences to Begin Trading its Common Stock on The Nasdaq Capital Market on July 2, 2021

SAN DIEGO, July 01, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW) today announced that the Company will begin trading its common stock...

LACQ : 14.4900 (unch)
LACQW : 1.0500 (unch)
Ensysce Biosciences to Commence Trading on the OTC on July 1, 2021

SAN DIEGO, June 30, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (OTC: LACQ, LACQW) today announced that, in connection with the closing of its previously announced...

LACQ : 14.4900 (unch)
LACQW : 1.0500 (unch)
Ensysce Biosciences’ Covistat Subsidiary “At Home Coronavirus Pill” Commencing to Phase 2 clinical development

Covistat to present pre-clinical data at American Thoracic Society annual meeting, May 14-19, 2021

LACQ : 14.4900 (unch)
LACQU : 12.7500 (-20.31%)
LACQW : 1.0500 (unch)
Ensysce Biosciences Receives Investigational New Drug Allowance for its Unique PF614-MPAR™ Opioid with Overdose Protection

NEW YORK and SAN DIEGO, April 29, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce”) and Leisure Acquisition Corp. (“LACQ”) (NASDAQ: LACQ, LACQU, LACQW) , a special purpose...

LACQ : 14.4900 (unch)
LACQU : 12.7500 (-20.31%)
LACQW : 1.0500 (unch)
Recro Expands Development and Manufacturing Relationship With Ensysce Biosciences

Additional Contract Broadens and Further Strengthens Customer Product Portfolio

LACQ : 14.4900 (unch)
LACQU : 12.7500 (-20.31%)
LACQW : 1.0500 (unch)
REPH : 2.09 (-0.48%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of Mergers

WILMINGTON, Del., March 16, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating:

FAII : 10.28 (+5.54%)
NSTB : 0.0630 (+4.13%)
ACND : 9.52 (+8.55%)
LACQ : 14.4900 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 16.1433
2nd Resistance Point 15.3167
1st Resistance Point 14.9033
Last Price 14.4900
1st Support Level 13.6633
2nd Support Level 12.8367
3rd Support Level 12.4233

See More

52-Week High 23.9900
Fibonacci 61.8% 18.6878
Fibonacci 50% 17.0500
Fibonacci 38.2% 15.4122
Last Price 14.4900
52-Week Low 10.1100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar